Low homoarginine/SDMA ratio is associated with poor short- and long-term outcome after stroke in two prospective studies

ConclusionThese results from two prospective stroke studies reveal that hArg/SDMA ratio could prove a valuable blood-based biomarker to discriminate patients with poor short- and long-term outcome, increased neurological impairment, and severe disability after stroke.
Source: Neurological Sciences - Category: Neurology Source Type: research